{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:03:50Z","timestamp":1761743030103},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.amjopharm.2007.09.001","type":"journal-article","created":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:58:50Z","timestamp":1196470730000},"page":"209-217","source":"Crossref","is-referenced-by-count":24,"title":["Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication"],"prefix":"10.1016","volume":"5","author":[{"given":"Brent","family":"Forester","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Vanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calixte","family":"Ahokpossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Sribney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley","family":"Adkison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2007.09.001_bib1","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/appi.ajp.157.10.1686","article-title":"Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: Initial results from the Depression in Alzheimer's Disease study","volume":"157","author":"Lyketsos","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2007.09.001_bib2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1176\/appi.ajp.157.5.708","article-title":"Mental and behavioral disturbances in dementia: Findings from the Cache County Study on Memory in Aging","volume":"157","author":"Lyketsos","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2007.09.001_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1176\/appi.neuropsych.14.1.11","article-title":"Estimating the prevalence of agitation and behavioral disturbance in community-dwelling persons with Alzheimer's disease","volume":"14","author":"Tractenberg","year":"2002","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.amjopharm.2007.09.001_bib4","first-page":"942","article-title":"Divalproex sodium in nursing home residents with possible or probable Alzheimer disease complicated by agitation: A randomized, controlled trial","volume":"13","author":"Tariot","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.amjopharm.2007.09.001_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000074278","article-title":"Pharmacologic management of agitation in Alzheimer's disease","volume":"17","author":"Profenno","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.amjopharm.2007.09.001_bib6","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa061240","article-title":"Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease","volume":"355","author":"Schneider","year":"2006","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.amjopharm.2007.09.001_bib7","first-page":"5","article-title":"Using antipsychotic agents in older patients","volume":"65","author":"Alexopoulos","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2007.09.001_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainres.2005.06.009","article-title":"Valproic acid potentiates both typical and atypical antipsychotic- induced prefrontal cortical dopamine release","volume":"1052","author":"Ichikawa","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.amjopharm.2007.09.001_bib9","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","article-title":"Combination of a mood stabilizer with risperidone or haloperidol fbr treatment of acute mania: A double-blind, placebo-controlled comparison of efficacy and safety","volume":"159","author":"Sachs","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"Suppl 2","key":"10.1016\/j.amjopharm.2007.09.001_bib10","first-page":"116","article-title":"Valproate use in neuropsychiatric disorders in the elderly","volume":"37","author":"Tariot","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.amjopharm.2007.09.001_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1176\/appi.ajgp.9.1.58","article-title":"Placebo- controlled study of divalproex sodium for agitation in dementia","volume":"9","author":"Porsteinsson","year":"2001","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.amjopharm.2007.09.001_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0011-393X(01)80042-4","article-title":"Safety and tolerability of divalproex sodium for the treatment of signs and symptoms of mania in elderly patients with dementia: Results of a double-blind, placebo-controlled trial","volume":"62","author":"Tariot","year":"2001","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.amjopharm.2007.09.001_bib13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/gps.653","article-title":"Sodium valproate in the treatment of aggressive behavior in patients with dementia\u2014a randomized placebo controlled clinical trial","volume":"17","author":"Sival","year":"2002","journal-title":"Int J Geriatr Psychiatry"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594607000426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594607000426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T10:23:40Z","timestamp":1546424620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594607000426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1543594607000426"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2007.09.001","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}